Skip to main content

Table 2 The biomarker serum phospholipid fatty acids in wt% and quartiles (P2575), n = 49

From: Validation of repeated self-reported n-3 PUFA intake using serum phospholipid fatty acids as a biomarker in breast cancer patients during treatment

Fatty acid, wt% Time 0 Time 6 Time 12
Median P25, 75 Median P25, 75 Median P25, 75
Sum n-3 10.24 8.03–11.54 9.33 8.07–11.12 9.31 7.99–10.85
EPA 2.54 1.84–3.17 2.23 1.56–2.79 2.19 1.53–3.03
DHA 6.24 5.44–7.13 6.10 5.13–6.73 5.84 4.97–6.72
  1. wt%: Weight percent
  2. time 0: 2–8 days presurgery, time 6: 6 months postsurgery, time 12: 12 months postsurgery
  3. Sum n-3: ALA (18:3n-3), EPA (20:5n-3), DPA (22:5n-3), DHA (22:6n-3)